Are ATTO insiders buying or selling?

Over the last 90 days, ATTO insiders were net buyers, reporting $185,029,614 of open-market purchases and $0.00 of sales.

When was the last ATTO insider purchase?

The most recent open-market purchase of Attovia Therapeutics, Inc. stock by an insider was reported on Aug 6, 2026, one of 17 purchases in the last 90 days.

Where does ATTO insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Attovia Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

ATTOSector not reported

Attovia Therapeutics, Inc. (ATTO) Insider Trading

In the last 90 days, 17 Attovia Therapeutics, Inc. (ATTO) insiders reported 17 open-market purchases totaling $185,029,614 and no sales. The most recent open-market purchase was reported on Aug 6, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $185,029,614
Corporate buyers: 17
Latest transaction: Aug 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Aug 6, 2026	Colin Walsh	Corporate insider	Open Market Purchase	690,807	$18.15	$12,536,627
Aug 6, 2026	Fhmls Xi L.P.	Corporate insider	Open Market Purchase	588,235	$17.00	$9,999,995
Aug 6, 2026	Frazier Life Sciences XI L.P.	10% Owner	Open Market Purchase	588,235	$17.00	$9,999,995
Aug 6, 2026	Fhmls Xi L.L.C.	Corporate insider	Open Market Purchase	588,235	$17.00	$9,999,995
Aug 6, 2026	Sanofi	10% Owner	Open Market Purchase	300,000	$17.00	$5,100,000
Aug 6, 2026	Redmile Group LLC	Corporate insider	Open Market Purchase	600,000	$17.00	$10,200,000
Aug 6, 2026	Jeremy Green	Corporate insider	Open Market Purchase	600,000	$17.00	$10,200,000
Aug 6, 2026	Redmile Biopharma Investments III L.P.	Corporate insider	Open Market Purchase	600,000	$17.00	$10,200,000
Aug 6, 2026	venBio Global Strategic Fund IV L.P.	10% Owner	Open Market Purchase	382,352	$17.00	$6,499,984
Aug 6, 2026	Goldman Sachs & Co. LLC	Corporate insider	Open Market Purchase	690,807	$18.15	$12,536,627
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]

🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

ATTO insider trading FAQ

Are ATTO insiders buying or selling?: Over the last 90 days, ATTO insiders were net buyers, reporting $185,029,614 of open-market purchases and $0.00 of sales.
When was the last ATTO insider purchase?: The most recent open-market purchase of Attovia Therapeutics, Inc. stock by an insider was reported on Aug 6, 2026, one of 17 purchases in the last 90 days.
Where does ATTO insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Attovia Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.